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OBJECTIVES: To characterise the phenotype of Border terriers suspected to be affected by canine 
 epileptoid cramping syndrome and to identify possible contributing factors.
METHODS: Owners of Border terriers with suspected canine epileptoid cramping syndrome were invited 
to complete an online questionnaire. The results of these responses were collated and analysed.
RESULTS: Twenty-nine Border terriers were included. Most affected dogs had their first episode before 
3 years of age (range: 0·2 to 7·0 years). The majority of episodes lasted between 2 and 30 minutes 
(range: 0·5 to 150 minutes). The most frequent observations during the episodes were difficulty in 
walking (27 of 29), mild tremor (21 of 29) and dystonia (22 of 29). Episodes most frequently affected 
all four limbs (25 of 29) and the head and neck (21 of 29). Borborygmi were reported during episodes 
in 11 of 29 dogs. Episodes of vomiting and diarrhoea occurred in 14 of 29, with 50% of these being 
immediately before or after episodes of canine epileptoid cramping syndrome (7 of 14). Most owners 
(26 of 29) had changed their dog’s diet, with approximately 50% (14 of 26) reporting a subsequent 
reduction in the frequency of episodes. 
CLINICAL SIGNIFICANCE: This study demonstrates similarities in the phenotype of canine epileptoid 
 cramping syndrome to paroxysmal dystonic choreoathetosis, a paroxysmal dyskinesia reported in 
humans. This disorder appears to be associated with gastrointestinal signs in some dogs and appears 
at least partially responsive to dietary adjustments.
INTRODUCTION
Paroxysmal dyskinesias are a group of movement disorders that 
are well described in human medicine. They are becoming 
increasingly recognised in animals (Meyers et al. 1969, Woods 
1977, Nakahata et al. 1992, Ramsey et al. 1999, Penderis & 
Franklin 2001, Kube et al. 2006, Harcourt-Brown 2008, Packer 
et al. 2010) although they are often poorly characterised in the 
veterinary literature. A movement disorder strictly speaking 
encompasses any abnormal involuntary movement, but is often a 
term applied to those disorders that do not impair consciousness. 
Dyskinesia is a general term to describe hyperkinetic movement 
disorders. These involuntary movements can include ballismus 
(abrupt contraction of limb muscles causing a flailing movement 
of the limb, this is often unilateral, as in hemiballismus), dys-
tonia (sustained involuntary contraction of a group of muscles 
producing abnormal postures), chorea (abrupt, non-sustained 
contraction of different groups of muscles in the same patient) 
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via solicitation through a contact (JG) involved in online sup-
port for owners of suspected CECS-affected BTs. All owners, 
subsequently involved in the online questionnaire agreed to their 
animal’s clinical details being interrogated.
Inclusion criteria
Inclusion criteria were in place to exclude other disease processes 
that may be misinterpreted as CECS. In the cases recruited via 
primary veterinarians full medical records were also requested 
and reviewed. The study was directed towards purebred BTs only. 
BTs were required to have at least a one-year history of episodes 
of abnormal involuntary hyperkinetic movement or muscle tone, 
without urination, defecation, hypersalivation or loss of con-
sciousness. Metabolic, cardiovascular, respiratory, orthopaedic 
and other neurological conditions were excluded as far as possible 
by full medical records, clinical examination findings and blood 
test results where available (only available in cases recruited from 
primary veterinarians). Episodes were reviewed by video footage 
where available or detailed telephone questioning of the owners. 
Once confirmed as likely sufferers, owners were invited to com-
plete an invitation-only online survey (this survey can be viewed 
at: http://www.surveymonkey.com/s/DVSCECS2012). 
Study design
Questions were embedded within the survey to further screen 
animals and respondents for answers not consistent with the defi-
nition of CECS for the purpose of exclusion from the study. The 
majority of questions were closed questions with multiple choice 
answers. Questions directed towards the characteristics of the 
episodes also included an opportunity to provide a description 
of the episodes with the following open question: “In your own 
words please describe in detail what happens during a typical epi-
sode, including 1. How the episodes look when they start, 2. How 
the episodes progress, 3. Whether your dog appears to be rigid or 
limp, or both, 4. Whether your dog tends to stand up/sit down/
lie down during an episode. If they vary then please describe how 
they tend to differ”. A total of 50 questions were divided into 
those that screened dogs for CECS as discussed above, and those 
that provided detailed phenotypic information in terms of the 
signalment of animals, possible precipitating factors, therapeu-
tic trials where relevant and the characteristics of the episodes. 
For the former, the owners were asked to describe the event in 
their own words but also to answer a number of questions about 
the events themselves including: duration and frequency of the 
and athetosis (prolonged contraction of trunk muscles causing a 
bending or writhing motion, this often accompanies chorea, thus 
is described as choreathetosis). Paroxysmal dyskinesia is the term 
ascribed to movement disorders when involuntary movements 
or postures are not continuous, but occur suddenly with normal 
motor function and no neurological deficits in between episodes. 
Paroxysmal dyskinesias are distinguished from simple focal sei-
zures by the character of the episodes including the movements 
observed, duration, triggers, absence of urination, defecation and 
hypersalivation (i.e. classic autonomic signs observed with sei-
zures), lack of postictal behaviour, and (with very few exceptions) 
lack of seizure activity on ictal EEG recordings (Demirkiran & 
Jankovic 1995, Packer et  al. 2010).
For human dyskinesias a modified classification system is 
applied based on precipitating factors, frequency, duration of 
attacks and response to treatment (Table 1) (Demirkiran & 
Jankovic 1995, Jankovic & Demirkiran 2002). Despite this, little 
is known about the underlying pathophysiology of the disease 
with the majority of cases appearing to be idiopathic or familial. 
However, recent advances include the identification of genetic 
mutations thought to be responsible for the disease (Lee et  al. 
2012, Groffen et  al. 2013).
Canine epileptoid cramping syndrome (CECS) or Spike’s Dis-
ease is a disorder affecting Border terriers (BTs) that veterinar-
ians have been aware of for over 10 years both in Europe and 
the USA, but which to date remains poorly characterised. It was 
hypothesised that this condition represents a breed-related par-
oxysmal dyskinesia. A survey was conducted of owners of BTs 
suspected to be suffering from CECS with the aim of characteris-
ing the phenotype and identifying possible contributing factors.
MATERIALS AND METHODS
Case recruitment
Cases were recruited by an appeal in the veterinary media (The 
Veterinary Times and Veterinary Record) for primary veterinary 
surgeons to respond with BTs in their care that were likely to be 
suffering from CECS. This specified cases that had been reported 
to exhibit episodes of gait abnormalities ranging from ataxia to 
an inability to stand; with contractions of the abdominal, neck 
and back muscles resulting in abnormal posturing, and contrac-
tions/cramping of the appendicular muscles causing extensor 
rigidity or flexion of the limbs. Additional cases were recruited 
Table 1 Human dyskinesia classification system, (D emirkiran & Jankovic 1995; Jankovic & Demirkiran 2002)
Type of movement disorder Age of onset Duration Frequency Trigger Response to 
AEDs
Paroxysmal kinesigenic choreathetosis (PKC)/
Paroxysmal kinesigenic dyskinesia (PKD)
Childhood/early 
adolescence
Typically <2 
minutes
High (up to 100 
per day)
Precipitated by sudden 
movements
Yes
Paroxysmal dystonic choreoathetosis (PDC)/
Paroxysmal non-kinesigenic dyskinesia (PNKD)
Childhood/early 
adolescence
5 minutes 
to 4 hours
Few per day-none 
for months
Alcohol, fatigue, caffeine, 
excitement
Not typically 
effective
Paroxysmal exertion induced dyskinesia (PED) Childhood/
early adolescence
5 to 30 
minutes
Daily-one per 
month
Precipitated by prolonged 
muscle exertion
Not typically 
effective
Paroxysmal hypnogenic dyskinesia (PHD) Childhood in familial, 
adulthood in sporadic
30 to 45 
seconds
5 times a night-5 
times a year
During non-REM sleep May be 
effective
AEDs antiepileptic drugs
V. Black et al.
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no change in  duration with time (19 of 29). Episode frequency 
overall was variable both between and within indivdiual BTs, 
with the majority of owners (15 of 29) reporting clusters over 
a few days interspaced by weeks or months of normality. Most 
BTs (16 of 29) had at some point experienced multiple episodes 
(up to 3) in a 24-hour period.
The majority of owners (18 of 29) felt they could predict an 
episode with their BTs becoming quieter (11 of 29), seeking to 
be near owners (6 of 29), vomiting bile or eating grass (4 of 29). 
Most owners (18 of 29) described similar behaviour after the 
episode, with dogs being quieter (11 of 29), seeking to be near 
owners (4 of 29) or hungry (3 of 29). Once an episode had com-
menced none of the respondents felt they were able to change the 
course of the episode. However, 23 of 29 owners elected to com-
fort their dogs by stroking or holding them during the episode. 
The most frequent observations during the episodes were dif-
ficulty walking (27 of 29), mild tremor (21 of 29) and dystonia 
(22 of 29). There was no observed trend between the propensity 
for BTs to stand up (14 of 29) or lie down (15 of 29) during an 
episode, although the majority of dogs (22 of 29) were reported 
to have periods when they were unable to stand. Less frequently, 
air licking (14 of /29), excessive stretching (14 of 29) and exten-
sor rigidity of all four limbs (14 of 29) were reported. Episodes 
most commonly affected all four limbs (25 of 29) and head and 
neck (21 of 29), with the back and abdomen (16 of 29) and tail 
(11 of 29) less frequently involved. Borborygmi were reported 
in 11 of 29 BTs during the episode. Twenty of the twenty-nine 
owners felt their dogs appeared to be uncomfortable during an 
episode. Some owners (10 of 29) felt that CECS had a negative 
impact on their dog’s quality of life.
Although the majority of episodes appeared to be totally ran-
dom (16 of 29), owners identified excitement (10 of 29), waking 
from sleep (13 of 29) and stress (9 of 29) as consistent circum-
stances of occurrence. Episodes did not appear to be induced 
by sudden movement. Fourteen of the twenty-nine BTs were 
reported to be prone to episodes of vomiting and diarrhoea with 
50% of these occurring immediately before or after episodes of 
CECS (7 of 14). Food intolerance was suspected in a number 
of BTs in this study (11 of 29). Another common complaint in 
affected BTs was skin disease (15 of 29), with no other signifi-
cant concurrent conditions being identified. Most owners (26 of 
29) had changed their BT’s diet after a suspicion of CECS was 
made, with the majority (19 of 29) selecting a diet that claimed 
to be hypoallergenic or a single protein and carbohydrate source. 
Over 50% of the dogs that participated in a diet change (14 of 
26) were felt by the owners to respond to this with a subsequent 
reduction in the frequency of episodes. Therapeutic trials with 
phenobarbital (5 of 29), potassium bromide (2 of 29), diazepam 
(3 of 29) and buscopan (3 of 29) appeared to fail in reducing the 
frequency or duration of episodes in the BTs in which they were 
trialled. The dosage of these medications was available in 5 cases 
(4 of 5 of the phenobarbital cases, 1 of 2 of the potassium bro-
mide cases, 2 of 3 buscopan cases) and was considered adequate 
in all cases (the doses were all greater than 3 mg/kg phenobarbital 
every 12 hours, serum phenobarbitone levels were available in 3 
of 5 phenobarbital cases and were within the therapeutic range). 
 episodes; body parts affected and the order of their involvement; 
types of movement; presence of autonomic signs such as saliva-
tion, urination or defecation; presence of borborygmi; awareness 
of the dog to its surroundings, ability to ambulate and presence 
of air licking.
RESULTS
There were 33 respondents to the request for cases in total, 20 
of 33 were from primary veterinary surgeons and 13 of 33 were 
from the contact. Four cases were excluded (2 of 20 from pri-
mary veterinary surgeons and 2 of 13 from the contact) as they 
did not meet the inclusion criteria. One respondent’s BT had 
been suffering from suspected episodes for a shorter time period 
than the designated 1 year required to fulfill inclusion criteria 
(1 month), one BT was reported to urinate during the episodes, 
one BT was reported to urinate and defecate during episodes and 
one BT reportedly salivated during the episodes. The remaining 
29 BTs were considered to be exhibiting CECS and the owners 
of these BTs were invited to complete the questionnaire. Episodes 
were reviewed by video footage (15 of 29) or detailed telephone 
questioning of the owners (14 of 29). Responses to the survey for 
all 29 BTs were analysed. Screening questions were investigated. 
No significant underlying metabolic, cardiovascular, respira-
tory, orthopaedic or other neurological conditions were identi-
fied in any respondent. For this reason, none of the 29 BTs were 
excluded at this stage. 
Blood tests were performed in 24 of 29 BTs including haema-
tology, biochemistry, electrolytes (immediately after an episode 
in 1 BT), thyroid blood tests (not specified), toxoplasma serol-
ogy, neospora serology, adrenocorticotropic hormone (ACTH) 
stimulation and pre and postprandial serum bile acids. One 
BT had biochemistry results consistent with pancreatitis and 
another was diagnosed with hypothyroidism. Four BTs had 
subclinical increases in liver parameters (alkaline phosphatase 
activity, alanine transaminase activity and serum bile acids) that 
were attributed to ongoing phenobarbital therapy at the time of 
sampling. All the other blood test results were reportedly within 
their respective reference intervals. Three of the twenty-nine BTs 
underwent magnetic resonance imaging and cerebrospinal fluid 
collection and analysis (cell count, cytology and protein con-
centration) and these results were reported as normal. All BTs 
had full clinical examinations performed by a veterinary surgeon 
and no abnormalities were detected. Three BTs had neurological 
examinations performed by board-certified neurologists: these 
findings were also normal.
Clinical cases
No sex predisposition was identified (15 of 29 males and 14 
of 29 females). The majority of BTs were neutered (25 of 29). 
Age at onset ranged from 0·2 to 7·0 years of age, with a mean 
and median age of 3·0 years. The mean duration for exhibit-
ing signs was 4·5 years (range: 1·0 to 11·0 years). The major-
ity of episodes were reported to last between 2 and 30 minutes 
(25 of 29) (range: 0·5 to 150 minutes). Most owners reported 
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30 seconds to 2·5 hours); this longer duration is also typical of 
PDC type paroxysmal dyskinesias, as is the variable but rela-
tively low frequency (discussed above). The lack of response to 
antiepileptic medications is also a finding consistent with PDC 
(Jankovic & Demirkiran 2002). Fatigue, excitement and stress 
have been reported to be triggers in humans with PDC/PNKD. 
This study identified a possible link with excitement, stress and 
waking from sleep in affected BTs, but this was not a consistent 
finding and the majority of episodes appeared to be random. 
Paroxysmal dyskinesias reported in the veterinary literature most 
commonly would be categorised as PDC/PNKC (Ramsey et  al. 
1999, Penderis & Franklin 2001, Packer et  al. 2010). One report 
described a paroxysmal dyskinesia typical of PKC/PKD in a Ger-
man shorthaired pointer (Harcourt-Brown 2008). Although not 
characterised in the literature as such, episodic falling syndrome 
in the Cavalier King Charles spaniel (Herrtage & Palmer 1983) 
and “scottie cramp” in Scottish terriers (Meyers et  al. 1969) are 
likely to represent fundamentally similar conditions (Penderis 
& Franklin 2001). At this stage the classification of the type of 
paroxysmal dyskinesia provides no information in terms of the 
likely aetiology or mechanism of the dyskinesia present. The 
neuroanatomical localisation of paroxysmal movement disorders 
is unknown although they are postulated to be due to abnor-
mal neurotransmission either because of an abnormality in the 
transmitter itself, ion channels or a cognate receptor (Comu et  al. 
1996, Ophoff et  al. 1996, Bressman et  al. 1998, Ptacek & Fu 
2002, Hamann et  al. 2003, Du et  al. 2005).
The main differential diagnosis for paroxysmal dyskinesia is 
focal seizures. It can be challenging in humans and animals to 
distinguish between the two (Beaumanoir et  al. 1996). Ideally, 
differentiation might be achieved using intra-ictal electroen-
cephalogram (EEG) monitoring (Demirkiran & Jankovic 1995, 
Beaumanoir et  al. 1996). Unfortunately, intra-ictal EEG record-
ing is rarely feasible in veterinary medicine because of the low 
likelihood of witnessing an event. Inter-ictal EEG recording is 
unlikely to be sufficiently sensitive to be relied upon for differ-
entiation. Inter-ictal EEG recordings in humans are reported to 
be sensitive in 29 to 55% of cases of epilepsy (Marsan & Zivin 
1970, Salinsky et  al. 1987, Goodin et  al. 1990), with a reported 
sensitivity of 65% in dogs (Berendt & Gram 1999). Intra-ictal or 
inter-ictal EEG recording was not performed on any BTs in this 
study, and the diagnosis of a paroxysmal dyskinesia was based on 
the overall phenomenology of the episodes in CECS. There are 
several reasons that this is considered more likely to represent 
a paroxysmal dyskinesia rather than epileptic seizures. During 
episodes BTs remained fully conscious throughout despite move-
ment affecting all four limbs, whereas if this was due to epilep-
tic seizure activity it would imply bilateral cerebral hemisphere 
involvement which would be expected to impair consciousness 
(Beaumanoir et  al. 1996). Simple focal seizures in which con-
sciousness is normally intact have clinical signs that are sugges-
tive of unilateral cerebral hemisphere involvement and therefore 
unilateral clinical signs (Licht et  al. 2002), this is not consistent 
with the generalised signs observed in BTs in this study. Fur-
thermore, simple focal seizures often progress to become gener-
alised or involve altered consciousness (Berendt et  al. 2004), this 
A dose of 2 mg and 5 mg diazepam was reportedly administered 
rectally in 2 of 3 cases and failed to abort the episode. 
DISCUSSION
This survey provides some important and useful clinical data 
concerning CECS in BTs. There appears to be no sex  predilection 
and the majority of BTs suffer their first episode before the age of 
three years. Similar findings in terms of the signalment of cases 
were reported in a recent study on paroxysmal dyskinesia in the 
Chinook (Packer et  al. 2010). The described duration of episodes 
was typically less than 30 minutes but could be significantly lon-
ger with apparent clustering over a few days (up to 3 in a 24 
hour period) interspaced with many weeks or months of nor-
mality. This pattern of variations in frequency has been reported 
in other breed-related movement disorders (Meyers et  al. 1969, 
Penderis & Franklin 2001) and suggests that CECS is a wax-
ing and waning disorder. Once an episode started owners felt 
they were unable to alter its course. Most episodes were charac-
terised by difficulty in walking, mild tremor and dystonia, with 
air licking, excessive stretching and extensor rigidity of all four 
limbs. Episodes often affected all four limbs and the head and 
neck, with the back and abdomen and tail commonly but less fre-
quently involved. Movement did not induce episodes and most 
were reported to be totally random in terms of circumstance of 
occurrence. However, owners identified excitement, waking from 
sleep and stress as possible triggers. Therapeutic trials with phe-
nobarbital, potassium bromide, diazepam and buscopan appar-
ently failed in all BTs in which they were attempted.
The majority of owners felt they could predict an episode with 
BTs becoming quieter, seeking to be near owners or vomiting 
bile or eating grass and similar behaviour was often noted after 
an episode. Such observed behavioural changes before and after 
episodes closely parallel pre and postictal behaviour associated 
with epileptic seizures; consequently movement disorders are at 
risk of being misidentified as seizure disorders, particularly when 
a clinician is unfamiliar with relevant breed-related disorders. 
Abnormalities in behaviour before and after episodes are by no 
means considered pathognomonic for a seizure disorder; prodro-
mal symptoms including headache, muscle tension, tingling and 
dizziness are reported in humans affected by paroxysmal dyski-
nesias before onset of an episode (Demirkiran & Jankovic 1995). 
Similar signs before onset of an episode appear to be possible in 
BTs affected by CECS. 
The phenotype for CECS revealed by this study suggests that 
it is consistent with a paroxysmal dystonic choreoathetosis/par-
oxysmal non-kinesigenic dyskinesia (PDC/PNKD) when using 
the modified classification scheme applied to paroxysmal dys-
kinesias in humans (Table 1) (Demirkiran & Jankovic 1995, 
Jankovic & Demirkiran 2002). CECS is not precipitated by 
movement, and does not occur exclusively during sleep making 
paroxysmal kinesigenic choreathetosis/paroxysmal kinesigenic 
dyskinesia (PKC/PKD), paroxysmal exertion induced dyskinesia 
(PED) and paroxysmal hypnogenic dyskinesia (PHD) less likely. 
The duration of episodes was typically 2 to 30 minutes (range: 
V. Black et al.
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In addition, the failure to respond to antiepileptic treatment was 
not directly investigated as dosage regimes and therapeutic con-
centrations were not specifically interrogated.
However, as with a recent study in Chinooks (Packer et  al. 
2010) the strength of this study lies in the consistent nature of 
the disorder in the breed rather than specific diagnostic findings. 
The definition used for BTs suffering from CECS was specific, 
and BTs exhibiting less stereotypical signs were excluded from the 
study. Some BTs suffering from CECS may therefore have been 
excluded from the study. However, a cohort of BTs strongly sus-
pected to be sufferers of CECS were included strengthening the 
phenotypic description such that further investigation including 
pedigree analysis for the mode of inheritance and a search for the 
candidate gene can be conducted. 
In conclusion, this study provides valuable information on 
the phenotype of CECS in the BT, a disorder hypothesised to 
be a paroxysmal dyskinesia, which should be classified as PDC/
PNKD when applying the human modified classification sys-
tem. This represents an important first step in the approach to 
investigating CECS. The ultimate aim is to achieve the same out-
come as that of episodic falling syndrome in the Cavalier King 
Charles spaniel, where the gene responsible for this disorder has 
been identified and a genetic test made available (Forman et  al. 
2012, Gill et  al. 2012). This work also highlights the need for 
further investigation into the role of the gastrointestinal system 
and dietary influences on this disorder. 
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